Cargando…
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)
BACKGROUND: Psoriasis patients carry an increased risk for associated comorbidities. Dermatologists have to be aware of the effects of systemic treatments not only on psoriasis but also on co‐occurring diseases. In case of other coexisting inflammatory diseases, the right psoriasis treatment may imp...
Autores principales: | Lambert, J.L.W., Segaert, S., Ghislain, P.D., Hillary, T., Nikkels, A., Willaert, F., Lambert, J., Speeckaert, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496856/ https://www.ncbi.nlm.nih.gov/pubmed/32791572 http://dx.doi.org/10.1111/jdv.16683 |
Ejemplares similares
-
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
por: Lambert, J.L.W., et al.
Publicado: (2020) -
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
por: Grine, L., et al.
Publicado: (2020) -
French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults
por: Amatore, F., et al.
Publicado: (2019) -
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019) -
French recommendations for the management of Takayasu’s arteritis
por: Saadoun, David, et al.
Publicado: (2021)